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Abstract.  An in vivo strategy to identify amino acids 
of actin required for functional interactions with actin- 
binding proteins was developed. This approach is 
based on the assumption that an actin mutation that 
specifically impairs the interaction with an actin- 
binding protein will cause a phenotype similar to a 
null mutation in the gene that encodes the actin- 
binding protein.  21  actin mutations were analyzed in 
budding yeast, and specific regions of actin subdo- 
main  1 were implicated in the interaction with 
fimbrin,  an actin filament-bundling protein.  Muta- 
tions in this actin subdomain were shown to be, like 
a null allele of the yeast fimbrin gene (SAC6), lethal 
in combination with null mutations in the ABP1 and 
S/_et2 genes, and viable in combination with a null 
mutation in the SLA/gene.  Biochemical experiments 
with act1-120 actin (E99A,E100A) verified a defect in 
the fimbrin-actin interaction. 
Genetic interactions between mutant alleles of the 
yeast actin gene and null alleles of the SAC6, ABP1, 
S/M/, and SLA2 genes also demonstrated that the 
effects of the 21  actin mutations are diverse and al- 
lowed four out of seven pseudo-wild-type actin alleles 
to be distinguished from the wild-type gene for the 
first time, providing evidence for functional redun- 
dancy between different surfaces of actin. 
T 
HE assembly and function of actin are influenced  by 
numerous protein-protein interactions  (Stossel et al., 
1985; Pollard and Cooper, 1986; Welch et al., 1994). 
The  development  of  molecular  models  for  monomeric 
(Kabsch et al., 1990) and filamentous  (Holmes et al., 1990) 
actin has created unprecedented opportunities to determine, 
at the atomic level,  how these protein-protein interactions 
mediate such varied processes as cytokinesis and cell loco- 
motion. However, while structural studies can reveal the spa- 
tial relationships  of atoms within proteins,  complementary 
approaches are required to determine how protein topology 
accounts for biological function. 
Chemical cross-linking  studies have been used to identify 
regions of actin that are part of or are proximal to the binding 
sites of specific actin-binding  proteins.  For example, profilin 
can be crosslinked to a glutamic acid (residue 364) of actin 
(Vandekerckhove  et al.,  1989).  In  addition,  cross-linking 
studies have provided evidence for interactions  between the 
acidic  NH2-terminus  of actin  (residues  1-12) and  several 
actin-binding  proteins,  including  depactin (Sutoh and Ma- 
buchi,  1986),  fragmin (Sutoh and Hatano,  1986),  and the 
heavy chain of myosin (Sutoh, 1982). Depactin and the myo- 
sin light  chain  can also be cross-linked to residues in the 
COOH terminus of actin (Sutoh, 1982; Sutoh and Mabuchi, 
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1986).  These results  are consistent with the fact that  the 
NH~ and COOH termini of actin are in close proximity to 
each other in the actin monomer (Kabsch et al.,  1990). 
An alternative  approach to the identification  of the con- 
tacts between actin and actin-binding  proteins is to perform 
structural  studies  on  complexes containing  actin  and  as- 
sociated proteins.  For example, the location of tropomyosin 
(Milligan  et al.,  1990)  and  scruin  (Owen and  DeRosier, 
1993) on the surface of the actin filament have been modeled 
through cryoelectron microscopy of tropomyosin- or scruin- 
coated actin filaments followed by image reconstruction. In 
other examples, the atomic structure of the gelsolin segment 
l:actin complex has recently been solved (McLaughlin et al., 
1993), and determination  of the atomic structure of the myo- 
sin head and development of a model for myosin complexed 
to actin filaments has identified amino acids of actin that are 
likely to be important for the acto-myosin cross-bridge cycle 
(Rayment et al.,  1993; Schr6der et al.,  1993). 
While these various forms of structural  analysis  provide 
opportunities for developing  deep mechanistic  understand- 
ings  of the  interactions  between actin  and various actin- 
binding  proteins,  each approach also has inherent  limita- 
tions.  For example,  studies using  electron microscopy and 
image reconstruction do not achieve atomic resolution.  Fur- 
thermore,  chemical  cross-linking  studies  that  attempt  to 
define the residues important for actin-actin-binding protein 
interactions  are limited by the chemical reactivity of amino 
acids. For example, several amino acid residues in the alpha- 
helix at positions 341-349 of the actin  monomer are part 
of a major contact site for myosin  (Rayment  et al.,  1993; 
Schr'oder  et al.,  1993),  but because of their hydrophobic 
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molecules.  In such a  situation, the chemical cross-linker 
might either fail to react with a residue on myosin, or might 
even react with a remote yet highly reactive amino acid of 
myosin. Moreover, while data derived from these various 
structural approaches can show that a particular residue of 
actin lies near a particular residue of an actin-binding pro- 
tein, and can suggest molecular mechanisms, such data do 
not test whether a residue of actin is directly involved in the 
actin-actin-binding protein interaction.  For these various 
reasons, the development of approaches that can identify ac- 
tin residues that are functionally important for interactions 
with actin-binding proteins in vivo is imperative. 
Site-directed mutagenesis can be used to determine the 
importance of specific actin residues for interactions with 
actin-binding proteins (reviewed by Wertman and Drubin, 
1992; Hennessey et al., 1993). This methodology is particu- 
larly powerful in Saccharomyces cerevisiae because the high 
frequency  of  homologous  recombination  allows  precise 
replacement of the wild-type actin gene by a single copy of 
any mutant gene engineered in vitro. This allows the effects 
of the mutation to be examined in vivo. Since ACT/encodes 
the sole source of conventional actin in budding yeast, it is 
possible to isolate biochemical quantities of a pure mutant 
actin, provided that the mutant actin can supply a sufficient 
level of  actin function in vivo. Furthermore, these mutant ac- 
tins can be used in in vitro assays to determine the impor- 
tance of specific residues for filament assembly (Chert et al., 
1993), actin-myosin interactions (Kron et al., 1992; Cook et 
al., 1993), and interactions with various other actin-binding 
proteins. 
A systematic "charged-to-alanine" mutational analysis of 
AC'iff designed to bias mutations to the surface of the mono- 
mer generated a large collection of  mutations in ACTI (Wert- 
man et al., 1992). Of the 36 act1 mutations constructed, 16 
are conditional-lethal alleles, and an additional seven alleles 
show no phenotype when expressed as the sole source of ac- 
tin in yeast cells (Wertman et al.,  1992).  Because most of 
the charged amino acid residues that were mutated reside on 
the surface of  the actin monomer, and because many different 
regions of actin were mutated, it is likely that the mutations 
affect  a variety of  the different  interactions made by actin. In- 
deed, the mutations cause a variety of different phenotypes, 
and one mutation abolishes binding to the mushroom toxin 
phalloidin (Wertman et al.,  1992;  Drubin et al.,  1993). 
We sought to develop a  genetic approach to determine 
which,  if any,  of the charged-to-alanine AC//  mutations 
affect the interaction between actin and actin-binding pro- 
teins. We hypothesized that such a mutation in the actin gene 
might cause a phenotype similar to a mutation in the gene 
that encodes the actin-binding protein.  For example, one 
hallmark of mutations in the fimbrin (SAC6) gene is syn- 
thetic lethality with mutations in ABPI and SLA2, genes that 
encode components of the actin cytoskeleton (Adams et al., 
1993;  Holtzman et al.,  1993).  By synthetic lethality, we 
mean that each single mutant is viable, but the combination 
of the two mutations results in inviability, presumably be- 
cause of redundancy in the functions provided by the prod- 
ucts of the two genes. Thus, a mutation in the actin gene that 
impairs the interaction with fimbrin would be predicted to 
show synthetic lethality with null alleles of the ABP1 and 
SLA2 genes, but not with null alleles of the SLA/and SAC6 
genes (see Results). Taking advantage of the large coUection 
of charged-to-alanine actl alleles, and knowledge of the pre- 
viously decribed synthetic lethal interactions involving the 
SAC6 gene, we have genetically implicated specific regions 
of actin subdomain 1 in the interaction between actin and 
fimbrin. Biochemical experiments verified our conclusions. 
The findings reported here demonstrate that the combination 
of genetic and structural data can create functional maps for 
the surfaces of proteins. 
Materials and Methods 
Yeast Methods 
Yeast media and genetic manipulations were performed as described (Rose 
et al.,  1990).  The strains used in this study are listed in Table I. For the 
experiments in Fig. 2, tetrads were dissected on rich media plates and grown 
for 3 d at 25°C before photography.  Ceils were replica plated (see Fig. 2 
B) using a multipronged replica-plating  device, and the growth properties 
of viable spores were examined at a variety of temperatures, as well as on 
selective plates, to follow segregation  of the marked actl (HIS3), abplA 
(1£02),  sac6A (LEU2),  s/a/& (URA3),  and s/a2A (URA3) alleles.  The 
plasmids used in this study are YCp50 (Mann, C., unpublished data; see 
Ma et al.  [1987] for a restriction map) and YCp50 containing wild-type 
SAC6 (AABll7) (Adams et al., 1991), or otherwise identical plasmids con- 
taining the sac6-6 (AAB122),  sac6-15 (AAB125),  and sac6-19 (AAB163) 
suppressor alleles (Adams and Botstein, 1989). For the experiments shown 
in Fig. 2 C, plasmids were transformed into diploid strains using lithium 
acetate/polyethylene  glycol as described (Ito et al.,  1983), and the trans- 
formed strains were subsequently  sporulated. 
ACT1 and actI-120 Actin Purification 
Yeast actins were purified as described (Kron et al., 1992). Briefly, cultures 
(ODtoo ,~8-10,  6 liters) of DDY354 (ACT/) and DDY347 (act1-120) were 
harvested at 4°C at 4,000 rpm. The pellet was washed 1× in 10 mM imida- 
zole/HCl (pH 7.4) and the cells were then resuspended in lysis buffer (10 
mM imidazole/HC1,  pH 7.4/0.5  mM CAC12/0.5 mM ATP with an aque- 
ous/ethanol protease inhibRor cocktail (1,000  x  aqueous inhibitors =  0.5 
mg/mi each antipain, leupeptin, pepstatin A, chymostatin, and aprotinin; 
100× ethanol inhibitors =  0.17 g PMSF,  1.6 nag benzamidine HC1, and 1 
rag phenanthroline  in 10 ml EtOH). Cells were lysed using a glass bead dis- 
ruption device with 30 cycles of 15 s agitation followed by a 45-s cooling 
interval. Disruption of cells was monitored by phase contrast microscopy 
and was typically >90%. The lysate was cleared with a low speed spin (12 
krpm, 60 rain, 4°(2) followed by a high-speed spin (42 krpm in a rotor 
[45Ti;  Beckman Instruments, Inc., Fullerton, CA],  120 rain, 4"C). The 
cytosol was diluted 1:1 with DNAse column buffer (10 mM imidazole/HCl, 
pH 7.4/0.5 mM CaCIz/0.5 mM ATP) and loaded at 0.5 ml/min onto a 2-ml 
column containing Sepharose-botmd  DNAse I (Worthington  Biochemical 
Corp.,  Freehold,  NJ).  The  DNAse  column  was  washed  with  several 
volumes of DNAse column buffer, followed by 10 ml each of 10% forma- 
mide in column buffer,  10% formamide/0.2  M NH4CI in column buffer, 
and then column buffer alone.  The outlet of the DNAse column was then 
connected to the inlet of a G-25 column (2.5  x  40 cm) equilibrated with 
DNAse column buffer. Actin was eluted from the DNAse column with 10 
mi of 50% formamide in column buffer, and protein-containing fractions 
collected  from the G-25 column were pooled and dialyzed  overnight in G 
buffer (5  mM  Tris/HCl,  pH  8.0/0.2  mM  CAC12/0.2 mM ATP/0.2  mM 
DTT). Actin was concentrated using a 5  x  50-ram (1 ml) Mono Q column 
using a fast protein liquid chromatography control system (Pharmacia LKB 
Biotechnnlogy Inc., Piscataway,  NJ) and eluted with a linear gradient of 
0-0.4 M KC1 in G buffer. 
Actin-Sac6p/Cofip Copelleting Assays 
Actin (3/~M) was assembled by the addition of one-tenth volume of 10 x 
polymerization-inducing buffer (10x polymerization-inducing  buffer is 20 
mM MgCI2/5 mM ATP, pH 7.0) in a final volume of 100/~1. Coflp was a 
generous gift of Anne Moon (Department of Molecular and Cell Biology, 
University of California, Berkeley,  CA)  and was  purified as described 
(Moon et al., 1993). Sac6p (yeast fimbrin), a generous gift of Tanya Sand- 
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Name  Genotype* 
DDY318 
DDY319 
DDY321 
DDY322 
DDY332 
DDY333 
DDY545 
DDY546 
DDY334 
DDY335 
DDY336 
DDY337 
DDY338 
DDY339 
DDY340 
DDY341 
DDY342 
DDY343 
DDY344 
DDY345 
DDY346 
DDY347 
DDY348 
DDY349 
DDY350 
DDY351 
DDY352 
DDY353 
DDY354 
DDY355 
DDY356 
DDY357 
DDY654 
MATs his3-A200,  Ieu2-3,112,  lys2-8Olam,  ura3-52 
sac6A: :LEU2 
MATs his3-A200,  Ieu2-3,112,  lys2-8Olam, ura3-52 
sac6A: :LEU2 
MATs his3-A200,  leu2-3,112,  ura3-52, 
abp  l-A2 :  :LEU2 
MATs his3-~200,  1eu2-3,112, ura3-52, 
abp I-A2: :LEU2 
MATc~ his3-A200,  ura3-52, slal-AI ::URA3 
MATe( his3-A200,  ura3-52, stal-AI ::URA3 
MATe( his3-A200,  1eu2-3,112, ura3-52, 
sla2-AI :  :  URA3 
MA Tct his3-A200,  1eu2-3,112, lys2-8O  lam, ura3-52, 
sla2-A1 :: URA3 
MATc~ ade2-101,  ura3-52, actl-4 
MATc~ his3-~200,  leu2-3,112,  ura3-52, tub2-201, 
act1-3 
MAT¢ his3-A200,  1eu2-3,112, ura3-52,  tub2-201, 
cryl,  canl-1, actl-133::HIS3 
MATc~ his3-A200,  leu2-3,112,  ura3-52, tub2-201, 
cry1, actl-lOS::HIS3 
MATc~ his3-A200,  leu2-3,112,  ura3-52, tub2-201, 
cry1, canl-1, actl-lOl::HlS3 
MATc~ his3-A200,  leu2-3,112,  ura3-52, tub2-201, 
ade2-101,  cry1,  can1-1, actl-lO2::HIS3 
MATc~ his3-A200,  leu2-3,112,  ura3-52,  tub2-201, 
canl-l, actl-lO4::HIS3 
MATe( his3-A200,  1eu2-3,112, ura3-52, tub2-201, 
ade2-101,  cry1 actl-lll::HIS3 
MATcc his3-A200,  1eu2-3,112, ura3-52, tub2-201, 
canl-1, actl-113: :  HIS3 
MATc~ his3-A200,  leu2-3,112,  ura3-52, tub2-201, 
ade2-101,  can1-1, act1-115::HIS3 
MATe( his3-A200,  leu2-3,112,  ura3-52,  tub2-201, 
canl-1, act1-116: :HIS3 
MAT~ his3-A200,  leu2-3,112,  ura3-52,  tub2-201, 
ade2-101,  cry  l , act  l- l l 7:  :  H1S3 
MATct his3-A200,  leu2-3,112,  ura3-52, tub2-201, 
ade2-101,  cryl, actl-119::HIS3 
MATe( his3-A200,  1eu2-3,112, ura3-52, tub2-201, 
canl-1, cryl , actl-120: :HIS3 
MATc~ his3-A200,  1eu2-3,112, ura3-52,  tub2-201, 
ade2-101,  canl-1, cry1,  actI-123::HIS3 
MATe( his3-A200,  1eu2-3,112, ura3-52,  tub2-201, 
actl-124::HIS3 
MATc~ his3-A200,  leu2-3,112,  ura3-52, tub2-201, 
actl-125::HIS3 
MATc~ his3-A200,  1eu2-3,112, ura3-52, tub2-201, 
canl-1, actl-129::HIS3 
MATc~ his3-A200,  1eu2-3,112, ura3-52,  tub2-201, 
ade2-101,  can1-1,  cryl, actl-132::HIS3 
MATc~ his3-A200,  1eu2-3,112, ura3-52,  tub2-201, 
ade2-101,  actl-135::HIS3 
MATct his3-A200,  leu2-3,112,  ura3-52, tub2-201, 
cryl , ACTI :  :HIS3 
MATct his3-A200,  1eu2-3,112, ura3-52,  tub2-201, 
ade4,  cryl, actl-ll2::HIS3 
MATc~ his3-A200,  leu2-3,112,  ura3-52, tub2-201, 
can1-1, actl-lOS::HIS3 
MATc~ his3-A200,  leu2-3,112,  ura3-52, tub2-201, 
act1-136: :HIS3 
MATce his3-A200,  1eu2-3,112, ura3-52,  tub2-201, 
can1-1, ade4,  actl-121::HIS3 
* All strains are derived from the $288C background. 
rock (Department of Molecular and Cellular Biology, University of Ari- 
zona, Tucson, AZ), is the first (and the most pure) of two Sae6p peaks that 
elute from a hyaroxyapatite column (Sandrock, T. S., and A. E. M. Adams, 
manuscript in preparation). Sae6p and Coflp were added to the reaction at 
'~0.1 t~M and 1.0/~M, respectively, before addition of polymerization salts. 
Polymerization was carried out at 22* for 1 h. Filaments were sedimented 
at 90 krpm for 40 min  at 22"C in a Beckman TLA table-top ultracentrifuge 
using  a TLA 100 rotor. To better separate the supernatants and pellets, at(in 
filaments were sedimented through a 50-t~! cushion of 50% sucrose in Ix 
polymerization buffer. For Sac6p pelleting  reactions,  supernatants were 
concentrated by "IUA  precipitation (Drubin et al., 1988). Pellets and super- 
natants were brought to the same total volume in 2x SDS sample buffer 
(2x SDS sample buffer is 125 mM Tris, pH 6.8/2% SDS/20% glycerol/ 
10% beta-mereaptoethanol/0.1% bromophenol blue), boiled for 3 rain, and 
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Figure 1. (A) Diagram showing synthetic-lethal interactions among 
components of the yeast cortical cytoskeleton. The lines connecting 
gene names signify synthetic-lethal interactions between null al- 
leles of each gene.  Each gene is nonessential for cell viability. 
When two genes are not connected by a line, no synthetic-lethal 
interaction occurs  between  null alleles  of the  two  genes.  (B) 
Schematic diagram illustrating the genetic principle for mapping 
protein-protein interactions on the actin filament. A null mutation 
in the SAC6 gene (sac6A) results in temperature sensitivity for cell 
growth (Adams et al.,  1991).  Therefore, a mutation in the ACT/ 
gene that disrupts the interaction between Sac6p and the surface of 
the actin filament is also predicted to result in temperature sensitiv- 
ity. Moreover, if such a mutant actin allele is combined with a null 
allele of ABP1 (abplA) (or a  null allele of SLA2 that was not in- 
cluded in this cartoon for simplicity), a synthetic-lethal interaction 
between these mutations is predicted to result, despite the fact that 
the disruption of ABP1 has no discernible effect in a wild-type actin 
background (Drubin et al.,  1990; Adams et al.,  1993; Holtzman 
et al., 1993). Therefore, by creating double mutants between mu- 
tant actin alleles and null alleles of  ABP1 and SAC6, and by looking 
for synthetic-lethal interactions, it should be possible to identify 
residues on the surface of actin that are important for the binding 
of Sac6p and/or Abplp. 
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of actin-actin  cytoskeletal pro- 
tein double mutants. (A) Spore 
colonies resulting from sporu- 
lation of actl-*/ +  abplA/+ 
diploids were grown for 3 d at 
25°C on rich medium. A syn- 
thetic-lethal defect results from 
combining the actld20 allele 
with  the  abplA  mutation. 
actl-120-abp1A double-mutant 
strains are either dead or ex- 
tremely sick. In contrast, act1- 
119 is unaffected by the abplA 
mutation. The actl-l13-abp1A 
interaction is an example of a 
modified permissive tempera- 
ture range effect (see also B). 
(B)  Example  of  a  modified 
permissive temperature range 
effect (MOD in Table ID. Rep- 
lica plating of a tetratype  tet- 
rad from a dissection  of a actl- 
113/+  abpl ~/  +  strain shows 
that the permissive tempera- 
ture range of the act1-113 al- 
lele is narrowed by addition of 
the abpla  allele.  Cells  were 
replica  plated  using a  multi- 
pronged replica-plating device, 
and the growth  properties  of 
viable spores  were  examined 
at a variety of temperatures. 
The  segregation  of  mutant 
genes was followed by scoring 
the  selectable  marker  genes 
linked to  each  mutant gene 
(i.e.,  LEU2  for  sac6~  and 
abpl-&l;  UR43  for  slal-&l 
and sla2-A2; and HIS3 for the 
actl  alleles).  This  analysis 
was used to compare the per- 
missive temperature range of 
each viable double mutant to 
the  permissive  temperature 
ranges  of the single mutants 
(Table ID. (C) Spore colonies 
from  tetrad  dissections  of 
actl-120/ +  abpl A/ +  strains 
transformed with centromere- 
based plasmids containing a 
dominant suppressor  allele of 
SAC6 (sac6'~P), the wild-type 
SAC6 gene, or a control plas- 
mid  (YCpS0). The  control 
plasmid has  no effect on the 
synthetic-lethal defect that re- 
sults from combining  the actl- 
120 allele with the abplA mu- 
tation. However, an allele of 
sac6 that suppresses  the tem- 
perature  sensitivity of actl-3 
also suppresses the synthetic- 
lethal  interaction  between 
actl-120 and abpl A (note that 
only 50% of the spore colonies are expected to inherit a plasmid in each cross). Increasing the copy number of the wild-type gene (SAC6) 
is able to enhance marginally the growth of the actl-120-abplA  double mutants that form colonies.  Tetrads were dissected on rich media 
plates  and were grown for 3 d at 25°C. 
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equal  volumes were loaded onto SDS-polyacrylamide gels as described 
(Laemmli,  1970). 
Electron Microscopy 
Electron microscopy of  negatively stained actin filaments was performed by 
the procedure of Millonig et ai. (1988),  except that 1% aqueous uranyl ace- 
tate was used. 
Results 
Genetic Interactions 
Our strategy to locate the binding sites of actin-binding pro- 
teins on the surface of actin is based on the expectation that 
mutations in the actin gene (AC77) that impair binding to a 
specific acfin-binding protein will cause a phenotype similar 
to that caused by a null mutation in the gene that encodes 
the actin-binding protein. For example, as shown in Fig.  1 
A, null alleles of SAC6 (the yeast fimbrin gene) are syntheti- 
cally lethal with null alleles of ABP1 (Adams et al.,  1993; 
Holtzman et al.,  1993) and SLA2, but not with null alleles 
of SLA/(Holtzman et al., 1993). Thus, actin mutants defec- 
tive in Sac6p (fimbrin) binding are predicted to be syntheti- 
cally lethal with abpl and s/a2 null alleles. This assumes that 
the phenotype of the actin-binding  protein mutant results 
from loss of the interaction with actin. Further predictions 
for an actin mutant that is defective in Sac6p binding are that 
the mutant will not show synthetic lethality with s/a/  and 
sac6 null alleles.  This is because sac6 null alleles do not 
show synthetic lethality with s/a/null alleles, and because 
the phenotype of an act1 mutant, whose phenotype results 
from a defective interaction with Sac6p, should not be made 
more  severe by deletion of the SAC6  gene.  The cartoon 
shown in Fig.  1 B which, for simplicity, shows only Sac6p 
and  Abplp,  illustrates  the  principle  behind  our  mapping 
strategy. A mutation in act1 that prevents Sac6p binding is 
predicted to cause a  temperature-sensitive phenotype (be- 
cause sac6A mutants are Ts-) and to be lethal in combina- 
tion with a null allele of ABP1. Accordingly, haploid strains 
containing mutations in ACT/(21 actl alleles were analyzed) 
were mated to null alleles of ABP1, SAC6, SIAl, and SLA2, 
and the double-heterozygotes were then sporulated and dis- 
sected. 
Each double mutant was analyzed as shown in Fig. 2 A. 
For those crosses in which the double mutant combination 
produced viable spores, spore colonies from tetratype tet- 
rads were replica plated and grown at several temperatures 
so that the growth of the wild-type strain, both single mu- 
tants  and the double mutant,  could be compared directly 
(Fig.  2 B).  The consequence of combining abplA, sac6A, 
s/a/A, or sla2A mutations with act1 alleles are classified in 
one of  three ways in Table II: (a) no effect  on the growth prop- 
erfies of the act1 Mutant (NE); (b) a modification of the per- 
missive temperature range (MOD); or (c) a synthetic-lethal 
effect (SL). An example of a modified permissive tempera- 
ture range is shown in Fig.  2 R  While strains bearing the 
act1-113 mutation grow well at 34  °, the act1-113-abp1A dou- 
ble mutant fails to grow at 34°C and grows poorly at 30°C 
(Fig. 2 B). Thus, the defect in the act1-113 strain is exacer- 
bated by the abplA mutation, even though the abplA allele 
alone has no discernible phenotype. An example of synthetic 
lethality between an act1 mutant allele and a null allele of 
a gene encoding a cytoskeletal protein is shown in Fig. 2 A. 
When an act1-120~+ abplA/+ strain was sporulated and ana- 
lyzed by tetrad dissection, a high percentage of the spores 
were found to be inviable (see Fig. 2 A). In all cases, the dead 
spores could be deduced by linked marker segregation (see 
Fig. 2 A legend and Materials and Methods) to contain both 
the act1-120 and abplA mutations (Table 11). Those double- 
mutant spores that did germinate were extremely sick (data 
not shown). Therefore, the act1-120 mutation is synthetically 
lethal with abplA. 
The data summarized in Table II show that abplA, sac6A, 
s/a/A,  and  sla2A  each  show  genetic  interactions  with  a 
different subset of the 21  act1 mutants analyzed. Interest- 
ingly, four out of seven pseudo-wild-type act1 alleles (act1- 
102, act1-115, act1-116, and act1-117) show enhancement, or 
even synthetic lethality, when combined with certain null 
mutations in cytoskeletal protein genes. Significantly, two of 
the 21 act1 mutations meet all four predictions for alleles that 
cause defects in the Sac6p-actin interaction.  These alleles 
(act1-3 and actM20) are synthetically lethal with sla2 and 
abpl  null alleles, but not with sial and sac6 null alleles. 
The only gene in addition to SAC6 that was analyzed in 
this study and that is known to encode an actin-binding pro- 
tein is ABP1. An act1 mutation that compromises the interac- 
tion between actin and Abplp is predicted to be unaffected 
by a null allele of ABP1. However, this same act1 mutation 
is  predicted to be  synthetically lethal with null  alleles of 
SAC6, SLAI, and SI.A2, since a double mutant of abplA and 
a null allele of  any of  these three genes is synthetically lethal. 
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Double-mutant phenotype 
actl  Amino acid  actl single  actl- *  actl- *  actl-*  actl-* 
Allele*  substitution(s)  mutant phenotype  sac6A  abplA  slalA  sla2A 
actl-lO1  D363A,E364A  "Is-  MOD*  MOD  NE  SL 
actl-102  K359A,E361A  WT  MOD  NE  UC§  NE 
actl-104  IO15A,E316A  WT  NE  NE  NE  NE 
act1-105  E311A,R312A  Cs-,Ts-  NE  NE  MOD  NE 
actl-108  R256A,E259A  Cs-,Ts-  SL  MOD  SL  SL 
actl-ll2  K213A,E214A,K215A  Cs-,Ts-  UC  SL  NDA  UC 
act1-113  R210A,D211A  Weak Ts-  SL  MOD  NE  NE 
actI-115  E195A,R196A  WT  SL  NE  NE  SL 
actl-ll6  D187A,K191A  WT  MOD  NE  NE  SL 
act1-117  R 183A,D 184A  WT  MOD  NE  NE  NE 
act1-119  R116A,E117A,K118A  Ts-  SL  NE  NE  UC 
act1-120  E99A,E100A  Ts-  NE  SL  NE  SL 
act1-121  E83A,K84A  Cs-,Ts-  SL  NE  ND  ND 
actl-123  R68A,E72A  WT  NE  NE  NE  NE 
act1-124  D56A,E57A  Ts-  SL  MOD  NE  SL 
act1-125  KSOA,D51A  Cs-,Ts-  SL  SL  NE  SL 
actl-129  R177A,D179A  Ts-  SL  SL  NE  SL 
actl-133  D24A,D25A  Cs-,Ts-  MOD  MOD  SL  SL 
actl-135  E4A  WT  NE  NE  NE  NE 
actl-136  D2A  Cs-,Ts-  SL  SL  UC  UC 
act1-3  P32L  Ts-  NE  SL  NE  SL 
Ts-, teraperature sensitive; WT, wild type; Cs-, cold sensitive. 
* For the location of each mutation on the atomic model of the actin monomer, and a complete description of the act/permissive temperature range, please see 
Wertman et al. (1992). 
* MOD, (modifier)  the double mutant has a permissive temperature range narrower than that of either single mutant; NE, no effect on the permissive temperature 
range; SL indicates that the double mutant is synthetically lethal. 
UC, uncertain. Viability of spores was too low to confer significance  to double-mutant  pbenotype. 
II ND, not determined. 
While one act1 allele (act1-115) meets three out of four of 
these expectations, it fails to show the predicted synthetic 
lethality with the s/a/null allele (Table 2). 
Suppression of  act1-120-abp1A Synthetic Lethality 
Adams and Botstein (1989) demonstrated that mutations in 
SAC6 can be isolated as dominant suppressors of the actl-3 
allele, and their genetic analysis of the actl-sac6 interaction 
strongly suggested that act1-3 actin is defective in its interac- 
tion  with  wild-type  Sac6p.  More  recently,  biochemical 
studies demonstrated that act1-3 actin filaments are indeed 
defective in the interaction with wild-type Sac6p (Honts et 
al., 1994). Recall that a sac6A-abplA double mutant is syn- 
thetically lethal. If the lethality that results from combining 
the act1-120 and abplA mutations is caused by a defect in the 
interaction between act1-120 filaments and Sac6p, then this 
is similar to having a cell that is sac6A and abplA. Therefore, 
restoring the Sac6p interaction with actin should suppress 
the act1-120-abp1A synthetic lethality. Since act1-3 and act1- 
120 have the same synthetic lethal interactions (Table II), we 
reasoned that mutant forms of Sac6p encoded by alleles of 
SAC6 (sac@  ~p) that suppress act1-3 might be able to interact 
functionally with act1-120 actin. Therefore, we determined 
whether the synthetic lethality of the actl-120-abp1A double 
mutant could be suppressed by sac6~ alleles. 
As  shown  in  Fig.  2  C,  actl-120-abp1A double-mutant 
strains are rescued by a sacO  ~p allele (sact-15, Adams and 
Botstein [1989]) borne on a centromere plasmid (the increase 
of spore viability by 50 %, rather than by 100%, is predicted 
based on the expected 2:2 segregation of centromere plas- 
mids; compare sac6~  " with YCp50 tetrad dissection, Fig. 2 
C, top and bottom, respectively). Moreover, these double- 
mutant strains grow in a sactop plasmid-dependent manner 
(data not shown). Interestingly, wild-type Sac6p expressed 
from a centromere-based plasmid also affects the actl-120- 
abplA double-mutant phenotype; those double-mutant spores 
that do germinate have a  broader permissive temperature 
range (20-30°C) than spores that carry a control plasmid 
(20-25"C) (data not shown). Thus, changing either the na- 
ture or the dosage of SAC6 can suppress the synthetic pheno- 
type of the actl-120-abplA double mutant. The same result 
was  obtained for actl-3-abplA  double mutants (data not 
shown). These results strongly suggest that, like actl-3 actin, 
actl-120 actin is defective in the interaction with Sac6p, and 
that it is this defect (mimicking a sac6A mutation) that re- 
sults in a synthetic-lethal interaction with abpla mutations. 
act1-120 Actin is Defective in the Interaction 
with Sac6p 
To determine the physical basis of the synthetic-lethal inter- 
actions between actl-120 and the abplA and s/a2A alleles, 
we purified actin from wild-type yeast and from a strain that 
bears the act1-120 mutation. The mutant actin assembled 
into filaments similar to those formed by the wild-type aetin 
as judged by electron microscopy (Fig. 3 A) and by velocity 
sedimentation assays (Fig.  3,  B  and C).  However,  while 
Sac6p associates with filaments assembled from wild-type 
yeast actin, the act1-120 mutation significantly impairs this 
interaction  (Fig.  3B).  In  five pelleting experiments,  the 
amount of Sac6p in the act1-120 actin pellet fraction varied 
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actin. (A) Electron micrograph of negatively stained filaments as- 
sembled from AC// and actl-120 actin (bar, 50 nM). (B) While 
Sae6p pellets with actin filaments composed of actin purified from 
ACT1 and actl-129 strains, the pelleting activity is impaired when 
actin purified from the actld20 mutant strain is used. S, super- 
natant;  P,  pellet.  Coomassie blue-stained  SDS-polyacrylamide 
(8.5%) gel. (C) Actin filaments composed of actin purified from 
the actld20 strain show  no defect in its association with the low mo- 
lecular weight actin-binding  protein Coflp (yeast cofilin). Coomas- 
sie blue-stained SDS-polyacrylamide  (13 %) gel. See Materials and 
Methods for experimental details. 
from being undetectable (not shown) to being noticeable but 
greatly reduced in amount compared to the amount in the 
wild-type actin pellet fraction (Fig.  3 B).  For the experi- 
ments in which some Sac6p was detectable in the actl-120 
pellet fraction, a  similar amount could be found in pellet 
fractions for control  reactions that lacked any actin  (not 
shown). Another temperature-sensitive mutation, actl-129, 
has no effect on the interaction with Sac6p (Fig. 3 B). The 
low molecular weight actin-binding protein Coflp (Moon et 
al.,  1993) copellets with both AC/7 and actl-120 filaments 
(Fig. 3 C), providing further evidence that the acd-120 mu- 
tation (E99A,E100A)  does not cause a gross defect in fila- 
ment  structure.  Thus,  the genetic  interactions accurately 
predicted a defect in the physical association of Sac6p with 
yeast actin filaments where the glutamic acid residues at po- 
sitions 99 and 100 have been replaced by alanine. 
Discussion 
To understand fully how actin-binding proteins regulate ac- 
tin assembly and organize higher order structures such as 
filament bundles, it is necessary to define the molecular con- 
tacts that these proteins make with the surface of  actin. Anal- 
ysis of the data compiled in Table H leads to four important 
conclusions concerning the functions and interactions of ac- 
tin and actin cytoskeleton proteins. The first point is that the 
abpl& sac6A,  s/a/~, and s/a2A mutations each show ge- 
netic interactions with a different subset of the 21 act1 mu- 
tations  analyzed.  This  demonstrates that the charged-to- 
alanine mutations in AC//have diverse effects on actin. This 
applies even for those cases in which two actl alleles have 
similar effects on cell growth. For example, despite the fact 
that actl-119 and act1-120 mutants have similar permissive 
temperature ranges (Wertman et al., 1992), combining these 
mutations with abplA and:sac6A have opposite effects (Table 
ID. The nonequivalence  of the conditional actl alleles is not 
surprising because tho mutations are distributed widely over 
the surface of the monmner and are therefore likely to affect 
different aspects of actin function. 
The second important conclusion arises from the observa- 
tion that while the s/a/A allele only shows interactions with 
three acd alleles, the abpl~, sac6~, and s/a2A alleles each 
affect 10-14 actl alleles, and each shows a distinct pattern 
of interactions with the act/mutations (Table 11). The differ- 
ences in the interactions with different act/alleles provide 
further evidence that although SAC6, SIAl, and SLA2 are all 
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al.,  1993),  their gene products play different roles in the 
regulation of the actin cytoskeleton. 
The third point is that the double-mutant analysis shows 
that the amino acids changed in four actin mutants for which 
no phenotype had previously been identified (actl-102, actl- 
115, act1-116, and act1-117) do indeed contribute to actin 
function. Thus, act1-115 appears to be wild type with respect 
to its permissive temperature range and sensitivity to os- 
motic stress (Wertman et al.,  1992). However, when com- 
bined with a null mutation in SAC6 or SLA2, actl-115 mu- 
tants  are  inviable  (Table II).  One  possibility  is  that  the 
act1-115 mutation impairs the ability of the mutant actin to 
bind to a protein whose interaction with actin is only impor- 
tant in the absence of Sac6p or Sla2p. Abplp would be such 
a candidate since abplA,  like act1-115, is synthetically lethal 
with sac6A and sla2A.  An observation that argues against 
this possibility is that the act1-115 allele is not synthetically 
lethal with the s/a/A mutation. This genetic interaction is ex- 
pected because abplA is synthetically lethal with s/a/A De- 
spite this discrepancy, it is possible that the "genetic redun- 
dancy" observed between ABP1 and SLAI is not manifested 
through  the  interaction  of Abplp  with  actin,  but  rather, 
through the interactions of the SH3 domains found on both 
Abplp and Slalp (Holtzman et al., 1993) with a common cel- 
lular ligand. Resolution of this issue will require biochemi- 
caUy assaying the interaction of purified Abplp with act1-115 
actin. 
The final important conclusion derived from the interac- 
tions summarized in Table II concerns the ability to geneti- 
cally implicate two act1 alleles  as  causing  defects in  the 
Sac6p-actin interaction. If a mutation in actin compromises 
the interaction between actin and Sac6p, then the deletion of 
SAC6 should cause no further detriment to the growth prop- 
erties of a  strain bearing that mutation. Therefore, an actl 
mutation that causes a defect in Sac6p binding is predicted 
to show no further detriment in growth when combined with 
a  sac6A  allele.  Furthermore,  such  an  actl  mutant  is 
predicted to show synthetic lethal interactions with abplA 
and s/a2A, but not with s/a/A (see Fig. 1 A). Of the 21 actl 
alleles analyzed,  only actl-3  (P32L) and actl-120 (E99A, 
E100A) meet these criteria (Table 11). 
The double-mutant results (Table 11) and the suppressor 
analysis with sac6  '~° alleles (Fig. 2  C) accurately predicted 
a defect in the association between Sac6p and filaments as- 
sembled from actl-120 (this study) and actl-3 (Honts et al., 
1994) actin. The actl-3 mutation is a change of proline at po- 
sition 32 to leucine (Shortle et al.,  1984). Because proline 
32 is buried in the actin monomer (Kabsch et al.,  1990), it 
is  not  likely  to  be  available  for  direct  interaction  with 
fimbrin, and alteration of this residue may have some effect 
on actin structure, a possibility that is consistent with the fact 
that actl-3  (Novick and Botstein,  1985) has a more severe 
phenotype than sac6A  (Adams et al.,  1991).  The actl-120 
mutation,  on the  other hand,  changes  two  glutamic  acid 
residues at positions 99 and 100 on the surface of an exposed 
loop of actin subdomain 1 (Holies et al.,  1990; Kabsch et 
al., 1990) to alanine (E99A, E100A) (Wertman et al., 1992) 
(Fig. 4), and therefore one or both of these glutamic acids 
might make direct contacts with Sac6p. The possibility that 
the primary defect of actl-I20 actin is in the interaction with 
Sac6p  is  further  supported by  the  fact that  the  actl-120 
phenotype (Wertman et al.,  1992; Drubin et ai.,  1993) is 
very subtle and is similar to the sac6A  phenotype both in 
terms  of the  effects on growth  and  on actin organization 
(Adams et al., 1991). Furthermore, if the actl-120 mutation 
Figure 4. Location of the actl- 
120  mutation  in  the  three 
dimensional model of the ac- 
tin filament (three monomers 
are  shown). Glutamic  acid 
residues 99 and  100 (white) 
arc exposed on the surface of 
the  filament in  actin  subdo- 
main 1. The purple and yellow 
monomers are located in the 
same strand of the two-start 
helix, while the red monomer 
lies in the adjacent strand. 
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cofilin, profilin, or tropomyosin, or a combination of these, 
a more severe defect in cell growth would be expected, since 
mutations in the genes that encode these actin-binding pro- 
teins result in severe phenotypes or even death (reviewed by 
Welch et al., 1994).  The observations that pure act1-120 ac- 
tin forms filaments that appear normal when analyzed by 
electron microscopy (Fig. 3 A) and when tested for the abil- 
ity to interact with cofilin (Fig. 3 C) further suggests that the 
act1-120 mutation only causes limited effects on the surface 
of actin. 
Since Sac6p contains actin-binding domains homologous 
to domains of ol-actinin, dystrophin, filamin, ~-spectrin, and 
actin-gelation protein (see Adams et al. [1991] and the refer- 
ences therein), each of these proteins is likely to interact 
with a similar region of the actin filament. Interestingly, in 
vitro studies have shown that oL-actinin can be cross-linked 
to a segment of actin (residues 87-119) (Mimura and Asano, 
1987) that contains residues 99 and 100. In addition, anti- 
bodies raised against actin residues 95-113 interfere with the 
interaction between o~-actinin and actin (Lebart et al., 1993). 
Recently, McGough et al. (1994) studied the structure of ac- 
tin filaments decorated with the actin-binding domain of 
o~-actinin using cryoelectron microscopy and image process- 
ing. Their results indicate that ~-actinin interacts with actin 
subdomain 1, the subdomain in which the act1-120 and act1-3 
mutations reside, and with actin subdomain 2. We note that 
the interaction between ot-actinin and F-actin is postulated to 
be predominantly hydrophobic in nature (Kuhlman et al., 
1992).  Sac6p binding, however,  is sensitive to salt concen- 
tration and thus is likely to have an electrostatic component 
(Drubin et al.,  1988). 
Actin residues 99 and I00 are likely to make electrostatic 
contacts with the S1 fragment of myosin (Schatz et al., 1986; 
Payment et al.,  1993;  Schrtder et al.,  1993),  and charge 
reversal of these residues in Dictyostelium  actin interferes 
with the ATP-driven translocation of actin filaments by myo- 
sin Oohara et al., 1993).  Since the act1-120 mutation is not 
a  charge reversal,  but a  change of the two glutamic acid 
residues to alanines, it is not possible to know without a di- 
rect test how this mutation will affect the interaction with 
myosin. However, as we point out above, an actin mutation 
that impairs the interaction of myosin with actin is predicted 
to have much more severe effects on cell growth than are ob- 
served for the act1-120 mutation, suggesting that myosin can 
functionally interact with act1-120 actin. While these con- 
siderations suggest that interactions with residues 99 and 
100 are more important for the interaction between actin and 
fimbrin than between actin and myosin, the implied prox- 
imity of the binding sites for fimbrin and myosin on actin 
suggests that fimbrin and myosin might compete for binding 
sites on the actin filament. In this regard, it is relevant that 
filamin, a protein that, like fimbrin, contains a domain ho- 
mologous to the actin-binding domain of a-actinin, appears 
to compete with myosin for an interaction site on actin (Da- 
vies et al.,  1977; Dabrowska et al.,  1985),  while oL-actinin 
does not (Malhotra et al.,  1986).  These and other studies 
suggest  that  ot-actinin  and  filamin have  overlapping  but 
nonidentical footprints on the actin filament (Lebart et al., 
1993).  Competition binding assays could be  used to test 
directly whether Sac6p binding inhibits the interaction of 
myosin, a-actinin, and/or filamin with actin filaments. 
More than 60 act1 alleles presently exist, and the number 
is growing steadily (e.g., Shortle et al., 1984; Johannes and 
Gallwitz,  1991; Cook et al.,  1992,  1993;  Wertman et al., 
1992; Chen et al., 1993). Since these mutations cover many 
of the surfaces of actin and presumably interfere with many 
different protein-protein interactions, they can be used to 
create a functional map of the surface of actin. One way to 
do  this  is  to  use  the  genetic  strategy  described  here. 
Moreover, since many synthetic lethal interactions have been 
observed between mutant cytoskeletal protein genes, the ap- 
proach can be extended to a  variety of actin-binding pro- 
tein-actin interactions. Thus, capping protein (encoded by 
CAP1 and CA/r2) mutants show synthetic lethality with sac6 
(Adams et al., 1993), as well as with slcl and slc2 (Karpova 
et al., 1993) mutants, and myosin (myo2) mutants show syn- 
thetic lethality with tropomyosin (tpm/) mutants (Liu and 
Bretscher,  1992). 
By isolating suppressors of  sac6 mutations that map to ac- 
tin subdomains 1 and 2, Honts et al. (1994) implicated a dus- 
ter of actin residues in the interaction with Sac6p (fimbrin). 
In addition, we (Wertman and Holtzman, unpublished ob- 
servation) and Honts, et al. (1994) combined sac6~ alleles 
with the conditional-lethal charged-to-alanine act1 alleles to 
test for genetic suppression. Significantly, act1-120, the allele 
shown here to encode an actin that is defective in the interac- 
tion with Sac6p, was suppressed by these suppressor alleles, 
adding further support to the conclusion that actin residues 
E99  and/or El00  are  important  for the  interaction  with 
fimbrin.  Suppression  was  observed  for  one  additional 
charged-to-alanine allele, act1-125 (K50A,D51A; actin sub- 
domain 2) (Honts et al.,  1994).  The act1-125 allele was not 
implicated in the interaction with Sac6p by the synthetic le- 
thal approach because this actl allele is synthetically lethal 
with sac6A (Table II). The synthetic lethality between actl- 
125 and sac6A indicates that this act1 allele affects more than 
the actin-Sac6p interaction. Otherwise, deletion of the SAC6 
gene should not make the act1-125 phenotype more severe, 
a prediction that was met for the act1-120 allele. Further- 
more, a sac6 null mutant is viable and grows well over a 
larger temperature range (Adams et al.,  1991) than an act1- 
125 mutant 0Vertman et al.,  1992).  Presumably, the sup- 
pressor  approach  implicated  act1-125 as  impairing  the 
Sac6p-actin  interaction because the interaction of the sac@~ 
protein  with  act1-125 actin  "repairs" or  compensates  for 
defects that may include, but certainly extend beyond, the 
Sac6p interaction. 
In conclusion, the application of a combination of  different 
genetic, biochemical, and structural approaches to problems 
of protein structure and function is necessary for gathering 
complementary information and for corroboration of con- 
clusions derived from each approach. 
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